Dergiler / Türk Dermatoloji Dergisi / 2020 / Cilt: 14 - Sayı: 4

High Prevalence of High‑Risk Cutaneous Squamous Cell Carcinoma in the Thrace Region of Turkey

Sayfa
83–89
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Clinicians should carefully evaluate the cSCCs in terms of high‑risk features.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background: The characteristics of cutaneous squamous cell carcinoma (cSCC) may show differences according to the geographic distribution and ethnicity.
📊
Temel Bulgular & Veri:Methods: We retrospectively investigated the biopsy‑proven cSCCs diagnosed between the years 2014 and 2018, in a tertiary university hospital and evaluated the high‑risk features.
💡
Sonuç & Katkı:Clinicians should carefully evaluate the cSCCs in terms of high‑risk features.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background: The characteristics of cutaneous squamous cell carcinoma (cSCC) may show differences according to the geographic distribution and ethnicity. Although most cSCCs are treated with surgical excision or other local interventions, high‑risk cSCCs may have poor outcome. In the present study, we aimed to evaluate the clinicopathological characteristics and determine the high‑risk features of cSCCs in the Thrace region of Turkey where the information on cSCCs is scarce. Methods: We retrospectively investigated the biopsy‑proven cSCCs diagnosed between the years 2014 and 2018, in a tertiary university hospital and evaluated the high‑risk features. Results: A total of 211 cSCCs were included. Men with cSCC were significantly younger than women with cSCC (P <.001). Almost one‑half of the tumors (n = 103) were located on the lower lip. Patients with a cSCC on the lower lip were younger than those with a cSCC on the other sites. All patients with a cSCC on the ears were men. Twenty‑eight percent of patients had tumor size more than 20 mm and 28% had tumor thickness more than 6 mm. Immunosuppression was present in 7.6% of patients. A total of 177 (83.9%) patients had high‑risk cSCC. The local recurrence rate was 6.2%, and the metastasis rate was 5.2%. Conclusions: The Thrace region has significant number of cSCC, and high‑risk features are very frequent. Clinicians should carefully evaluate the cSCCs in terms of high‑risk features.

🔖

Bu Makaleye Atıf Yap

SOLAK, S. S., YÖNDEM, H., URUN, Y. G., CEZİK, M., CAN, N. (2020). High Prevalence of High‑Risk Cutaneous Squamous Cell Carcinoma in the Thrace Region of Turkey. Türk Dermatoloji Dergisi, Cilt: 14 - Sayı: 4, 83–89. https://ajindex.com/articles/399029

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Kallini JR, Hamed N, Khachemoune A. Squamous cell carcinoma of the skin: Epidemiology, classification, management, and novel trends. Int J Dermatol 2015;54:130‑40
  2. Lai V, Cranwell W, Sinclair R. Epidemiology of skin cancer in the mature patient. Clin Dermatol 2018;36:167‑76
  3. Bander TS, Nehal KS, Lee EH. Cutaneous squamous cell carcinoma: Updates in staging and management. Dermatol Clin 2019;37:241‑51
  4. Veness MJ. Defining patients with high‑risk cutaneous squamous cell carcinoma. Australas J Dermatol 2006;47:28‑33
  5. Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus‑based interdisciplinary guideline. Eur J Cancer 2015;51:1989‑2007
  6. Motaparthi K, Kapil JP, Velazquez EF. Cutaneous squamous cell carcinoma: Review of the eighth edition of the american joint committee on cancer staging guidelines, prognostic factors, and histopathologic variants. Adv Anat Pathol 2017;24:171‑94
  7. Chu MB, Slutsky JB, Dhandha MM, Beal BT, Armbrecht ES, Walker RJ, et al. Evaluation of the definitions of “high‑risk” cutaneous squamous cell carcinoma using the american joint committee on cancer staging criteria and national comprehensive cancer network guidelines. J Skin Cancer 2014;2014:154340
  8. Koyuncuer A. Histopathological evaluation of non‑melanoma skin cancer. World J Surg Oncol 2014;12:159
  9. Eroğlu A, Berberoğlu U, Berreroğlu S. Risk factors related to locoregional recurrence in squamous cell carcinoma of the skin. J Surg Oncol 1996;61:124‑30
  10. Ulkur E, Karagoz H, Acikel C, Yuksel F, Celikoz B. The recurrence frequency of nonmelanotic skin cancers: A retrospective analysis over 11 years. Cerrahpasa J Med 2005;36:189‑93
  11. Akturk A, Yildiz KD, Bilen N, Bayramgürler D, Kıran R, Onyedi M. Skin cancer cases admitted to Kocaeli University Medical Faculty between years 1996 and 2003. Turk Klin J Dermatol 2006;16:44‑9
  12. Ceylan C, Oztürk G, Alper S. Non‑melanoma skin cancers between the years of 1990 and 1999 in Izmir, Turkey: Demographic and clinicopathological characteristics. J Dermatol 2003;30:123‑31
  13. Turkmen A, Berberoglu O, Bekerecioglu M, Mutaf M. Skin cancers: Retrospective analysis of 10 years. Gaziantep Tıp Dergisi 2010;16:11‑5
  14. Bas Y, Kalkan G, Pancar GS, Seckin HY, Müslehiddinoğlu A. Skincancer cases admitted to tokat state hospital between years 2007 and 2011. Turk J Dermatol 2014;2:84‑7
  15. Guneren E, Neimetzade T,